<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="4813">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03044275</url>
  </required_header>
  <id_info>
    <org_study_id>CP265_08</org_study_id>
    <nct_id>NCT03044275</nct_id>
  </id_info>
  <brief_title>The Influence of Output on Skin Covered by Adhesive With Topfilm</brief_title>
  <official_title>The Influence of Output on Skin Covered by Adhesive With Topfilm</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coloplast A/S</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Coloplast A/S</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study investigates the impact real output has on peristomal skin covered by a newly
      developed adhesive with topfilm and a standard adhesive with a topfilm.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 16, 2017</start_date>
  <completion_date type="Anticipated">March 2017</completion_date>
  <primary_completion_date type="Anticipated">March 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Trans epidermal water loss</measure>
    <time_frame>6 hours</time_frame>
    <description>the condition of the skin (trans epidermal water loss) is measured after removing the adhesive from the skin</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">4</enrollment>
  <condition>Ileostomy - Stoma</condition>
  <arm_group>
    <arm_group_label>Cohort 8</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This is a sub-study testing the effect of real output on the skin applied under two adhesive strips.
New adhesive strip Standard adhesive strip</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>New adhesive strip</intervention_name>
    <description>This is a newly developed adhesive strip that in the future might be part of an ostomy device</description>
    <arm_group_label>Cohort 8</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard adhesive strip</intervention_name>
    <description>This is a standard adhesive strip (hydrocolloid). The adhesive is a part of an ostomy device</description>
    <arm_group_label>Cohort 8</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Have given written informed consent

          2. Be at least 18 years of age and have full legal capacity

          3. Have had an ileostomy for more than one year

          4. Have intact skin on the area used in the evaluation

          5. Has an ileostomy with a diameter up to (â‰¤) 35 mm

          6. Have a peristomal area accessible for application of patches/adhesive strips
             (assessed by investigating scientist)

        Exclusion Criteria:

          1. Currently receiving or have within the past 2 month received radio- and/or
             chemotherapy

          2. Currently receiving or have within the past month received topical steroid treatment
             in the peristomal skin area or systemic steroid (tablet/injection) treatment.

          3. Are pregnant or breastfeeding

          4. Having dermatological problems in the peristomal- or abdominal area (assessed by
             investigating scientist)

          5. Participating in other interventional clinical investigations or have previously
             participated in this evaluation -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lene Feldskov, M. Sci</last_name>
    <role>Principal Investigator</role>
    <affiliation>Head of preclinical department</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marian Sinivani</last_name>
    <email>dkmards@coloplast.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Coloplast A/S</name>
      <address>
        <city>Humlebaek</city>
        <zip>3050</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lene F Nielsen</last_name>
      <email>dklfn@coloplast.com</email>
    </contact>
    <investigator>
      <last_name>Lene F Nielsen</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 6, 2017</lastchanged_date>
  <firstreceived_date>January 31, 2017</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
